Stay updated on Adjuvant Nivolumab for Stage II Melanoma Clinical Trial
Sign up to get notified when there's something new on the Adjuvant Nivolumab for Stage II Melanoma Clinical Trial page.

Latest updates to the Adjuvant Nivolumab for Stage II Melanoma Clinical Trial page
- Check6 days agoChange DetectedAdded a new revision entry v3.5.4 to the Study Record Versions, and removed the previous revision v3.5.3 from the history. This reflects an updated revision in the study's revision history.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page footer was updated to reflect a new ClinicalTrials.gov revision number (from v3.5.2 to v3.5.3). This represents an interface/version update rather than a change to the trial record history itself.SummaryDifference0.1%

- Check34 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded Revision: v3.5.0 to the Record History and removed Revision: v3.4.3.SummaryDifference0.1%

- Check70 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 from the history.SummaryDifference0.1%

- Check98 days agoChange DetectedRevision: v3.4.2 was added to the history, and the government funding lapse notice along with Revision: v3.4.1 were removed from the visible history.SummaryDifference0.7%

Stay in the know with updates to Adjuvant Nivolumab for Stage II Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adjuvant Nivolumab for Stage II Melanoma Clinical Trial page.